Close

Orexigen (OREX) to Update on Contrave Progress During Dec. 18th Event

December 4, 2012 8:09 AM EST Send to a Friend
Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced that the Company will provide details of obesity therapeutics market research including the results ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login